Prenetics Global Limited's wellness brand IM8 has closed a $1 billion growth financing deal with General Catalyst’s Customer Value Fund, which will cover up to 70% of IM8’s marketing spend. This non-dilutive financing allows IM8 to accelerate its expansion across 43 countries while preserving Prenetics’ balance sheet. IM8, co-founded by David Beckham, is the fastest-growing premium supplement brand, with revenue guidance raised to $210–220 million for 2026 and expectations to reach $300 million by year-end. The funding supports IM8’s AI-driven marketing engine and ongoing product innovation, positioning the brand for over $400 million in revenue in 2027 and long-term global leadership in consumer health.
Sperax, creator of the auto-yield stablecoin USDs and SperaxOS AI agent workspace, has become an official IBM Business Partner. This partnership combines Sperax's AI-driven DeFi technology with IBM's enterprise AI and cloud infrastructure, enabling r...
HoodDomains has introduced .hood domains on the Robinhood Chain, replacing complex wallet addresses with human-readable names that serve as trader profiles, payment endpoints, and AI agent identities. These domains are fully on-chain NFTs, enabling s...
Wells Fargo reported strong Q2 2026 results with earnings per share of $2.00 and revenue of $22.62 billion, both exceeding analyst expectations. The growth was driven by strong fee income and better credit performance. Despite this, the stock price d...
KKR & Co. Inc. is spearheading a significant A$400 million financing deal for Ampol Limited, showcasing its strong global investment strategy and robust asset management. Despite Bank of Montreal lowering KKR's price target to $112 from $120, the fir...
Stellantis shares have fallen nearly 47% over the past year due to weak financial results, dividend cuts, and a revenue decline in 2025. Despite this, the company reported a 10% increase in Q2 vehicle shipments and plans to launch a new Alfa Romeo mi...
